Active	Status	Sponsor type	Region	Phase	Filter
2 Active 3 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Beissert, Stefan
NCT06602219: A Study of LY4100511 (DC-853) in Adult Participants With Moderate-to-Severe Plaque Psoriasis	Recruiting	2	220	Canada, Japan, US	LY4100511, Placebo	DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company	Plaque Psoriasis	07/25	08/25
NCT04944862: A Study of CDX-0159 in Patients With Prurigo Nodularis Nov 2023 - Nov 2023 : Topline data from trial for prurigo nodularis	Completed	1	24	Europe, US	CDX-0159, barzolvolimab, Normal saline	Celldex Therapeutics	Prurigo Nodularis	07/23	07/23